AstraZeneca said Friday it has filed for approval of its coronavirus vaccine in Japan, becoming the second major pharmaceutical firm
Continue reading »
Home »
First investigational drug therapy for liver disease NASH awaiting FDA approval
Patients with nonalcoholic steatohepatitis (NASH), a chronic liver disease and a leading cause for liver transplantation in the U.S., currently
Continue reading »
Alnylam Announces Plan to Initiate Rolling Submission of a New Drug Application and Pursue Full Approval for Givosiran
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Oct. 15, 2018– Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced that in consultation
Continue reading »
Ivosidenib earns FDA approval against IDH1+ acute myeloid leukemia
Clinical trials at University of Colorado Cancer Center and elsewhere now result in the drug ivosidenib earning approval from the
Continue reading »
FDA grants first approval for CA drug under new pilot programs
(HealthDay)—The U.S. Food and Drug Administration has approved ribociclib (Kisqali) in combination with an aromatase inhibitor (AI) as an initial
Continue reading »
FDA expands approval of closed-looped insulin delivery system
(HealthDay)—Approval of the MiniMed 670G hybrid closed looped system for diabetes management has been expanded to include individuals aged 7
Continue reading »